What is the recommended management for bacterial conjunctivitis, including first‑line topical antibiotics and supportive care?

Management of Bacterial Conjunctivitis

For mild bacterial conjunctivitis in immunocompetent adults, a 5-7 day course of any broad-spectrum topical antibiotic is recommended, with selection based on convenience and cost rather than specific agent superiority. 1

Severity-Based Treatment Algorithm

Mild Bacterial Conjunctivitis

Clinical presentation: Mucopurulent discharge with eyelids matted shut on waking, minimal pain, no vision changes 1, 2

Treatment approach:

• Topical antibiotics shorten symptom duration by 1-2 days and reduce transmissibility, allowing earlier return to school or work 1, 3, 4
• Select any broad-spectrum topical antibiotic for 5-7 days based on cost and convenience—no specific antibiotic has proven superiority 1
• Topical antibiotics improve clinical cure by 26% compared to placebo, with 68% achieving resolution versus 56% with placebo by days 4-9 3
• Alternative option: Povidone-iodine 1.25% ophthalmic solution may be equally effective when antibiotic access is limited 1

Important caveat: While most cases resolve spontaneously without treatment, antibiotics provide faster clinical and microbiological remission during days 2-5, with benefits persisting but diminishing through days 6-10 1, 5

Moderate to Severe Bacterial Conjunctivitis

Clinical presentation: Copious purulent discharge, pain, marked inflammation 1

Immediate actions:

• Obtain conjunctival cultures and Gram stain if gonococcal infection is suspected 1
• Consider MRSA, which shows increasing frequency and resistance to many topical antibiotics 1
• Microbiology-guided therapy may require compounded topical vancomycin for MRSA 1

Gonococcal Conjunctivitis

Systemic therapy (mandatory):

• Adults: Ceftriaxone 1g IM single dose PLUS azithromycin 1g PO single dose (for concurrent chlamydia) 1
• Children ≤45 kg: Ceftriaxone 25-50 mg/kg IV/IM single dose (max 250 mg) 1
• Children >45 kg: Same as adult dosing 1

Adjunctive measures:

• Saline lavage promotes comfort and faster resolution 1
• Topical antibiotics (optional but usually added) 1
• Daily follow-up required until resolution with visual acuity and slit-lamp examination 1
• Treat sexual contacts and screen for concomitant STDs 1
• Consider sexual abuse in children 1

Chlamydial Conjunctivitis

Systemic therapy (mandatory):

• Adults: Azithromycin 1g PO single dose OR doxycycline 100 mg PO twice daily for 7 days 1
• Pregnant women: Azithromycin 1g PO single dose OR amoxicillin 500 mg PO three times daily for 7 days (avoid doxycycline) 1
• Children ≥8 years: Azithromycin 1g PO single dose OR doxycycline 100 mg PO twice daily for 7 days 1
• Children <8 years but >45 kg: Azithromycin 1g PO single dose 1
• Infants/children <45 kg: Erythromycin 50 mg/kg/day divided four times daily for 14 days 1

Critical considerations:

• Systemic therapy is essential because >50% of infants have infection at other sites (nasopharynx, genital tract, lungs) 1
• No evidence supports adding topical therapy to systemic treatment 1
• Treatment failure occurs in up to 19% of cases—re-evaluation is mandatory 1
• Treat sexual contacts simultaneously and screen for concomitant STDs 1
• Monitor infants on erythromycin for pyloric stenosis (especially <6 weeks old) 1

Neonatal Conjunctivitis (Ophthalmia Neonatorum)

Gonococcal:

• Ceftriaxone 25-50 mg/kg IV/IM single dose (max 250 mg) 1
• Alternative: Cefotaxime 100 mg/kg IV/IM single dose 1

Chlamydial:

• Erythromycin 50 mg/kg/day divided four times daily for 14 days 1
• Alternative: Azithromycin suspension 20 mg/kg/day once daily for 3 days 1

Prophylaxis at birth:

• Erythromycin 0.5% ophthalmic ointment single application to each eye 1

Supportive Care Measures

• Artificial tears for symptom relief 2, 6
• Cold compresses for comfort 2, 6
• Strict hand hygiene to prevent transmission 2

Follow-Up Guidelines

• Gonococcal conjunctivitis: Daily visits until resolution 1
• Other bacterial conjunctivitis: Return in 3-4 days if no improvement 1
• Chlamydial conjunctivitis: Re-evaluation after treatment completion due to high failure rates 1
• CDC recommends retesting at 3 months for gonococcal or chlamydial infections 1

Red Flags Requiring Ophthalmology Referral

• Neonatal conjunctivitis 2
• Severe pain or decreased vision 2
• Recent ocular surgery 2
• Vesicular rash on eyelids or nose (herpetic) 2
• Immunocompromised state 2
• History of rheumatologic disease 2